Kuranda et al. also reported that a small subpopulation of cycling CD34+CD138+B7-H1+CD19− plasma cells were found in MM patients, and these cells often expressed Ki67, a marker for proliferation, and limited the clinical benefits of autologous CD34+ cell transplantation [127]. This evidence concerns the gene CD34 and Miyoshi myopathy.